跳至主要内容
临床试验/EUCTR2012-000622-22-ES
EUCTR2012-000622-22-ES进行中(未招募)不适用

Aspirin for the enhancement of trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks of gestation - NA

Fundació Clínic per a la Recerca Biomèdica0 个研究点开始时间: 2012年5月10日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • -Patients over 18 years old attending for routine ultrasound at first trimester of pregnancy between 11 and 14 weeks of gestation (Crown-to rump length: 45-48 mm)
  • -Single gestation
  • -Mean pulsatility index of the uterine arteries above the 95th percentile for our population
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 270
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Pre-existing hypertension, renal or cardiovascular disease
  • - previous history of preeclampsia
  • -Pregestational diabetes
  • -Systemic Lupus Erythematosus
  • -Gastric ulcer
  • -Acetylsalicylic acid or lactose Hypersensitivity
  • -Bleeding disorders
  • Fetal malformations (including chromosomal abnormalities)
  • -Administration of low molecular weight heparin
  • - concomitant treatment with aspirine

研究者

发起方
Fundació Clínic per a la Recerca Biomèdica

相似试验